Copyright
©The Author(s) 2022.
World J Gastrointest Surg. Jun 27, 2022; 14(6): 580-593
Published online Jun 27, 2022. doi: 10.4240/wjgs.v14.i6.580
Published online Jun 27, 2022. doi: 10.4240/wjgs.v14.i6.580
Table 1 Prognostic analysis of clinical characteristics in patients with gastric cancer
Clinical variable | n | Univariate analysis | Multivariate analysis | ||
312 | HR (95%CI) | P value | HR (95%CI) | P value | |
Age (yr) | 62 (54-68) | 1.046 (1.015-1.077) | 0.003 | 1.049(1.017-1.081) | 0.002 |
Sex (male/female) | 225/87 | 0.715 (0.400-1.280) | 0.259 | ||
BMI (kg/m2) | 21.55 (19.53-23.55) | 0.983 (0.911-1.062) | 0.670 | ||
Smoking (yes/no) | 64/248 | 0.442 (0.189-1.034) | 0.060 | ||
Drinking (yes/no) | 49/263 | 1.316 (0.641-2.701) | 0.454 | ||
CEA (ng/mL) | 2.94 (1.85-5.29) | 1.006 (1.003-1.009) | 0.000 | ||
CA19-9 (U/mL) | 13.26 (7.36-23.70) | 1.001 (1.000-1.002) | 0.003 | ||
CA125 (U/mL) | 8.50 (5.90-13.80) | 1.008 (1.000-1.016) | 0.049 | ||
CA72-4 (IU/mL) | 1.81 (1.17-4.46) | 1.004 (0.990-1.018) | 0.57 | ||
HAR | 3.18 (2.68-3.44) | 0.425 (0.278-0.650) | 0.000 | 0.466 (0.301-0.720) | 0.001 |
PHR | 1.86 (1.40-2.58) | 1.371 (1.194-1.575) | 0.000 | ||
PLR | 157.74 (114.06-211.23) | 1.003 (1.001-1.006) | 0.004 | ||
PAR | 5.75 (4.51-7.48) | 1.184 (1.088-1.288) | 0.000 | ||
FLR | 2.05 (1.49-2.89) | 1.171 (1.018-1.347) | 0.028 | ||
AFR | 13.16 (10.36-16.85) | 0.970 (0.912-1.033) | 0.344 | ||
HFR | 42.52 ± 17.83 | 0.974 (0.955-0.993) | 0.007 | ||
PFR | 77.41 (57.84-101.46) | 1.005 (0.998-1.012) | 0.135 | ||
NLR | 2.47 (1.76-3.59) | 1.100 (0.974-1.242) | 0.124 | ||
ALR | 26.25 (22.16-35.08) | 1.008 (0.986-1.030) | 0.489 | ||
Tumor size (cm) | 4.0 (2.5-5.5) | 1.167 (1.079-1.262) | 0.000 | ||
Vascular infiltration (present/absent) | 168/144 | 3.230 (1.695-6.153) | 0.000 | ||
Nerve infiltration (present/absent) | 149/163 | 2.974 (1.651-5.359) | 0.000 | ||
Histological grade (G1/G2/G3) | 6/120/186 | 0.920 (0.553-1.530) | 0.748 | ||
Stage (Ⅰ/Ⅱ/Ⅲ) | 88/75/149 | 4.154 (2.291-7.531) | 0.000 | 4.112 (2.225-7.602) | 0.000 |
Survival status (death/survival) | 53/259 | ||||
Follow-up time (d) | 531 (440-691) |
- Citation: Hu CG, Hu BE, Zhu JF, Zhu ZM, Huang C. Prognostic significance of the preoperative hemoglobin to albumin ratio for the short-term survival of gastric cancer patients . World J Gastrointest Surg 2022; 14(6): 580-593
- URL: https://www.wjgnet.com/1948-9366/full/v14/i6/580.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v14.i6.580